The Clinical Operations and Development team at Attralus Therapeutics is responsible for overseeing the design, planning, and execution of clinical trials aimed at evaluating potential treatments for systemic amyloidosis. This team ensures compliance with regulatory standards, manages project timelines, and coordinates cross-functional efforts to facilitate data collection and analysis, ultimately driving the progression of innovative therapies from the lab to patients.
Daniel Kim
Associate Director, Translatio...
Dave Conroy
Head of Program Management
Jennifer Simpson
Director of Clinical Operation...
Jim Carlson
Vice President, Head of Projec...
Joseph Suttner
Vice President, Clinical Opera...
Matthew Meldorf
Senior Vice President Clinical...
Ryan Taylor
Sr. Director Of Clinical Opera...
View all